Axsome Therapeutics, Inc. (AXSM)

164.08 +0.03 (+0.02%) USD  |  NASDAQ  |  Mar 04, 16:00
164.16 +0.08 (+0.05%) Pre-Market: 20:00
More

Axsome Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade